News & Announcements

Faculty Receive Seed Funding as Part of MTTC Acorn Innovation Fund

Three research projects at UMass Amherst are among 13 at colleges and universities across the state sharing $195,000 in seed funding from the Massachusetts Technology Transfer Center (MTTC) Acorn Innovation Fund. 

The $15,000 grants were awarded to researchers from the UMass system, Boston University Medical Center, Northeastern University, Tufts University and Western New England University to assist them in testing the viability of their technologies and potentially bringing their research to market.

At UMass Amherst, Byung H. Kim, and Yubing Sun, mechanical and industrial engineering, received a grant for a project titled, “A SERS-based immunoassay for cancer biomarkers detection.”Kim and Sun have developed a novel SERS-based antigen detection system that can quantify the concentration of biomarker with ultra-high sensitivity, reproducibility, and low cost. With Acorn funding, they hope to improve the technology so that it can be used to detect cancers in their early stage to increase the survival rate of patients. The funding allows them to test their technique to detect four different type of cancers: lung, liver, ovarian and pancreatic. Read more

Sam Hazen's Contributions to Scientific Entrepreneurship Featured in UMass Magazine Story: After Eureka

Professor Sam Hazen

Scary though it may seem, Baima and other UMass scientists can be bold in their entrepreneurial efforts—the UMass Institute for Applied Life Sciences (IALS) has their backs. IALS was launched in 2015 to help turn scientific discoveries into marketable products that improve human health and well-being.

IALS works in step with the Berthiaume Center for Entrepreneurship at the Isenberg School of Management, with the office of the Vice Chancellor for Research and Engagement through its Office of Technology Transfer and the UMass Innovation Institute, and other entities to fortify the campus start-up culture. The interdisciplinary institute includes 250 faculty from 28 academic departments and manages unique resources. These include state-of-the-art equipment organized into core facilities accessible to academic labs and industry alike, interdisciplinary lab space organized into research themes that allow faculty from different departments and even from different colleges to work close together, and lab space for start-up companies. Faculty, students, industry leaders, and entrepreneurs mingle in the institute’s conference spaces. To operate IALS, the university contributed more than $60 million in capital funds and operational support. The Commonwealth of Massachusetts itself is behind IALS, having invested $95 million through the Massachusetts Life Sciences Center. Read more

Professor Sam Hazen's Contributions to Scientific Entrepreneurship Featured in UMass Magazine Story: After Eureka

Professor Sam Hazen

Scary though it may seem, Baima and other UMass scientists can be bold in their entrepreneurial efforts—the UMass Institute for Applied Life Sciences (IALS) has their backs. IALS was launched in 2015 to help turn scientific discoveries into marketable products that improve human health and well-being. Read more

Katz, Lyzinski to Explore Neuron-Level Mechanisms of How Brains Make Decisions

photo of Paul Katz

Paul Katz, professor of biology and director of neuroscience, and Vincent Lyzinski, a network expert and assistant professor of mathematics and statistics, recently received a three-year, $3.5 million grant from the NIH’s National Institute of Neurological Disorders and Stroke for a new collaboration between researchers at four universities who will explore the neuron-level mechanisms of how the brain makes decisions.

The project is part of President Obama’s 2013 Brain Research through Advancing Innovative Neurotechnologies (BRAIN) initiative at NIH, which seeks to accelerate the development and application of new technologies leading to “a revolutionary new dynamic picture of the brain that, for the first time, shows how individual cells and complex neural circuits interact in both time and space.” Read more

UMass Amherst researchers studied origins of adverse effects of a common anti-cancer treatment

Results of a new study by neuroscientists at the University of Massachusetts Amherst suggest that a new treatment approach is needed – and how this may be possible – to address adverse effects of aromatase inhibitors, drugs commonly prescribed to both men and women to prevent recurrence of estrogen-positive breast cancer.

Neuroscientists Agnès Lacreuse, Luke Remage-Healey and their graduate students at UMass Amherst, collaborator Jessica Mong at the University of Maryland and first author Nicole Gervais worked together on this research. Gervais, who conducted the experiments as a postdoctoral researcher at UMass Amherst, is now at the University of Toronto. The authors studied a small group of aged male and female marmosets, non-human primates whose brains are much like humans’ and which exhibit “complex behavior,” senior author Lacreuse explains. (Read more)

Researchers Study Dormant Cancer Cells and What Causes Them to Reawaken

photo of Jungwoo Lee

Researchers led by chemical engineer Jungwoo Lee are developing microenvironments that allow them to study how cancer cells that move around the human body change from dormant to active. Understanding this process, the researchers say, could lead to treatments to prevent cancer from metastasizing. Read more

NSF Supports UMass Amherst Scientists Creating New Discipline

A team of three researchers at the University of Massachusetts Amherst recently was awarded a three-year grant from a new National Science Foundation program to pursue an unusual intersection of their disciplines, which aims to grow an entirely new field, “touch-based bacterial communication,” on their campus and beyond. Polymer scientist Maria Santore, physicist Mark Tuominen and microbiologist Sloan Siegrist will receive $975,000 from NSF’s new “Convergence Program,” which aims to create new fields of study to address scientific issues by bringing together investigators from disciplines that are somewhat removed from each other, Santore explains. Read more

TARGET: BREAST CANCER

UMass scientists discover what causes this insidious disease and how to prevent it.

Breast cancer begins with one lethal rogue cell. Cancerous cells in the breast then grow out of control in a mind-boggling process that researchers worldwide have yet to fully understand, despite years of study and billions of dollars in funding.  At the University of Massachusetts Amherst, researchers in many areas, backed by government organizations and private foundations, are attacking breast cancer on multiple fronts. They are investigating environmental toxins and breast milk, leading large epidemiological studies, creating new treatments, identifying individuals likely to get breast cancer, and advocating for changes in chemical testing and regulation. Read more

Twelve UMass Amherst Researchers Among Most Highly Cited in the World

Twelve researchers at UMass Amherst, including MCB faculty Vince Rotello and Hang Xiao, have been recognized for being among the world’s most highly cited researchers in 2018. The analysis by Clarivate Analytics, owner of Web of Science, serves as the basis for regular listings of researchers whose citation records put them in the top 1 percent by citations for their field and year. Read more

Rare and Diverse Giant Viruses Unexpectedly Found in a Forest Soil Ecosystem

photo of Jeff Blanchard and colleagues

Until recently, scientists thought of viruses as mostly small infectious agents, tiny compared to typical bacteria and human cells. But biologist Jeff Blanchard and Ph.D. student Lauren Alteio with others at the U.S. Department of Energy’s Joint Genome Institute have discovered giant viruses – relatively speaking the size of Macy’s Thanksgiving Day Parade balloons – in soil at Harvard Forest in Petersham. Read more

Pages